Ha ha ha freakin ha ha ha. Enrolling candidates by the end of 2022! Not long now! I've marked this quote of yours down.
By the time the patent is expected to kick in, the trial will be close to fully enrolled, won't it?
Ha ha ha. Good one, Hector!
It comes in handy for the MEND trial also.
Outside of the CYP SHs on HC, I get the distinct impression that CYP as a company that is positioning itself for a FDA approval for stem cells?
And from what I've read, I don't think that approval is for a CYP product? Is there any other companies out there that have done MSC P3 trials with the FDA and are in negotiation currently?
Start praying, like Ross and Dr Kilian Kelly guys. Oh, the irony. We are all cheering on the same company....whether we like it or not.
CYP Price at posting:
30.0¢ Sentiment: None Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)